Clinical significance of PSMA, TERT and PDEF in malignant tumors of the prostate.

Situ J, Zhang H, Lu L, Li K, Hu C, Wang DJ

DOI: 10.26355/eurrev_202110_26971
Published: 2021 Oct
Container: European review for medical and pharmacological sciences
Publisher: Not recorded
Open access: unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.26355/eurrev_202110_26971,
  title = {Clinical significance of PSMA, TERT and PDEF in malignant tumors of the prostate.},
  author = {Situ J and Zhang H and Lu L and Li K and Hu C and Wang DJ},
  year = {2021},
  journal = {European review for medical and pharmacological sciences},
  doi = {10.26355/eurrev_202110_26971},
  url = {https://doi.org/10.26355/eurrev_202110_26971}
}

RIS

TY  - JOUR
TI  - Clinical significance of PSMA, TERT and PDEF in malignant tumors of the prostate.
AU  - Situ J
AU  - Zhang H
AU  - Lu L
AU  - Li K
AU  - Hu C
AU  - Wang DJ
PY  - 2021
JO  - European review for medical and pharmacological sciences
DO  - 10.26355/eurrev_202110_26971
UR  - https://doi.org/10.26355/eurrev_202110_26971
ER  -

APA

J, S., H, Z., L, L., K, L., C, H., & DJ, W. (2021). Clinical significance of PSMA, TERT and PDEF in malignant tumors of the prostate.. European review for medical and pharmacological sciences. https://doi.org/10.26355/eurrev_202110_26971

Source records

pubmed · retrieved 2026-09-25T09:13:28.592Z